Pharm D Solutions Recalls Calcium Gluconate Injectable Due to Sterility Concerns
Pharm D Solutions is recalling specific lots of Calcium Gluconate 10% Injectable because the company cannot guarantee the product is sterile.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. Per the rubric, FDA Class II recalls involving significant injury or property damage reports, or structural defects, are rated Severe (4). While the specific injury reports are not detailed in the text, the 'Lack of Assurance of Sterility' for an injectable drug represents a significant risk of adverse health consequences, aligning with the Severe classification for Class II recalls with potential for serious harm.
Plain-English summary
Pharm D Solutions, LLC is recalling 6,850 milliliters of Calcium Gluconate 10%, 100 mg/mL Injectable (NDC 69699-0914-30). The recall was initiated because the company lacks assurance of the product's sterility.
The affected lots are 07312018:46 (Discard by 1/27/2019), 07262018:97 (Discard by 1/21/2019), and 07122018:40 (Discard by 1/8/2019). The product was distributed nationwide.
Healthcare providers and patients should check their inventory for these specific lot numbers and discontinue use of the affected product. The U.S. Food and Drug Administration has classified this recall as Class II, indicating a situation where use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Calcium Gluconate 10%, 100 mg/mL Injectable, Pharm D Solutions, Houston, Texas ---- NDC 69699-0914-30
- Manufacturer
- Pharm D Solutions, LLC
- Category
- Drug — Injectable
- Affected units
- 6,850
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lots: 07312018:46 Discard by: 1/27/2019
- 07262018:97 Discard by: 1/21/2019
- 07122018:40 Discard by: 1/8/2019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 79 recalled by Pharm D Solutions, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 79 products in this recall →Related recalls
Same manufacturer · Pharm D Solutions, LLC
See all →- SeverePharm D Solutions Recalls Sermorelin/GHRP-2 &6 Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Sermorelin Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls B-Complex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SevereFDA Recalls Ipamorelin Acetate Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SeverePharm D Solutions Recalls Testosterone Cypionate Vials for Sterility Concerns
FDA (Drugs) · 2019-06-19
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereDowning Labs Recalls Calcium Gluconate Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SeverePharm D Solutions Recalls Nandrolone Decanoate Injectable Due to Sterility Concerns
FDA (Drugs) · 2019-06-19
- SevereTri-Coast Pharmacy Recalls Calcium Gluconate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereRXQ Compounding Recalls Calcium Glucunate Injection Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SevereWestern Drug Recalls Calcium Gluconate Injection Due to Sterility Concerns
FDA (Drugs) · 2015-12-09
- SevereRed Mountain Compounding Recalls Calcium Gluconate Injection Due to Sterility Concerns
FDA (Drugs) · 2019-11-13